India Pharmaceuticals and Healthcare Report in India

1
India Pharmaceuticals and Healthcare Report in
India
Market Reports On India
Market Reports On India
By http//www.marketreportsonindia.com/

2
Summary

• Pharmaceutical firms continue to post varying
  results in India due to the government's
• introduction of policies targeting the
  pharmaceutical industry. These include patent
  disrespect and pricecontainment
• policies for both generic and patented drugs. We
  maintain our bearish view on the sector and
• highlight that domestic firms with a large
  exposure to overseas markets will continue to
  fare well.
• Headline Expenditure Projections

Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
3
Pharmaceuticals INR840.0bn (US15.7bn) in 2012
to INR921.2bn (US16.5bn) in 2013 9.7 in
local currency terms and 4.6 in US dollar
terms. Forecast broadly in line with Q313,
although growth in US dollar terms was impacted
by the depreciation of the rupee. Healthcare
INR3,811.2bn (US71.3bn) in 2012 to INR4,209.7bn
(US75.2bn) in 2013 10.5 in local currency
terms and 5.4 in US dollar terms. Forecast
broadly in line with Q313, although growth in US
dollar terms was impacted by the depreciation of
the rupee.


Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
4
Table of Contents
Industry View Table Commercial Banking Sector
Indicators Table Commercial Banking Key Ratios,
April 2013 Table Annual Growth Rate
Projections, 2012-2017 () Table Ranking Out Of
69 Countries Reviewed In 2013 Table Commercial
Banking Sector Indicators, 2010-2017 SWOT
Commercial Banking Political Economic
Business Environment Industry Forecast



Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
5
To view the full Executive Summary and Table of
Contents, please visit India Pharmaceuticals and
Healthcare Report in India Contact us Market
Reports on IndiaPhone no912227810772 /
73E-mail to info_at_marketreportsonindia.com
Website https//www.marketreportsonindia.com